Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis

Yasuyuki Ohta, Genevieve Soucy, Daniel Phaneuf, Jean Nicolas Audet, François Gros-Louis, Guy A. Rouleau, Hélène Blasco, Philippe Corcia, Peter M. Andersen, Frida Nordin, Toru Yamashita, Koji Abe, Jean Pierre Julien

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Recent genetic studies yielded conflicting results regarding a role for the variant chromogranin B (CHGB)P413L allele as a disease modifier in ALS. Moreover, potential deleterious effects of the CHGBP413L variant in ALS pathology have not been investigated. Here we report that in transfected cultured cells, the variant CHGBL413 protein exhibited aberrant properties including mislocalization, failure to interact with mutant superoxide dismutase 1 (SOD1) and defective secretion. The CHGBL413 transgene in SOD1G37R mice precipitated disease onset and pathological changes related to misfolded SOD1 specifically in female mice. However, the CHGBL413 variant also slowed down disease progression in SOD1G37R mice, which is in line with a very slow disease progression that we report for a Swedish woman with ALS who is carrier of two mutant SOD1D90A alleles and two variant CHGBP413L and CHGBR458Q alleles. In contrast, overexpression of the common CHGBP413 allele in SOD1G37R mice did not affect disease onset but significantly accelerated disease progression and pathological changes. As in transgenic mice, the CHGBP413L allele conferred an earlier ALS disease onset in women of Japanese and French Canadian origins with less effect in men. Evidence is presented that the sex-dependent effects of CHGBL413 allelic variant in ALS may arise from enhanced neuronal expression of CHGB in females because of a sex-determining region Y element in the gene promoter. Thus, our results suggest that CHGB variants may act as modifiers of onset and progression in some ALS populations and especially in females because of higher expression levels compared to males.

Original languageEnglish
Pages (from-to)4771-4786
Number of pages16
JournalHuman Molecular Genetics
Volume25
Issue number21
DOIs
Publication statusPublished - 2016

Fingerprint

Chromogranin B
Amyotrophic Lateral Sclerosis
Alleles
Disease Progression
Transgenes
Transgenic Mice
Cultured Cells
Pathology
Population
Genes
Proteins

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Ohta, Y., Soucy, G., Phaneuf, D., Audet, J. N., Gros-Louis, F., Rouleau, G. A., ... Julien, J. P. (2016). Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis. Human Molecular Genetics, 25(21), 4771-4786. https://doi.org/10.1093/hmg/ddw304

Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis. / Ohta, Yasuyuki; Soucy, Genevieve; Phaneuf, Daniel; Audet, Jean Nicolas; Gros-Louis, François; Rouleau, Guy A.; Blasco, Hélène; Corcia, Philippe; Andersen, Peter M.; Nordin, Frida; Yamashita, Toru; Abe, Koji; Julien, Jean Pierre.

In: Human Molecular Genetics, Vol. 25, No. 21, 2016, p. 4771-4786.

Research output: Contribution to journalArticle

Ohta, Y, Soucy, G, Phaneuf, D, Audet, JN, Gros-Louis, F, Rouleau, GA, Blasco, H, Corcia, P, Andersen, PM, Nordin, F, Yamashita, T, Abe, K & Julien, JP 2016, 'Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis', Human Molecular Genetics, vol. 25, no. 21, pp. 4771-4786. https://doi.org/10.1093/hmg/ddw304
Ohta, Yasuyuki ; Soucy, Genevieve ; Phaneuf, Daniel ; Audet, Jean Nicolas ; Gros-Louis, François ; Rouleau, Guy A. ; Blasco, Hélène ; Corcia, Philippe ; Andersen, Peter M. ; Nordin, Frida ; Yamashita, Toru ; Abe, Koji ; Julien, Jean Pierre. / Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis. In: Human Molecular Genetics. 2016 ; Vol. 25, No. 21. pp. 4771-4786.
@article{b64529bec14c41b08879f3c5c3aae15b,
title = "Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis",
abstract = "Recent genetic studies yielded conflicting results regarding a role for the variant chromogranin B (CHGB)P413L allele as a disease modifier in ALS. Moreover, potential deleterious effects of the CHGBP413L variant in ALS pathology have not been investigated. Here we report that in transfected cultured cells, the variant CHGBL413 protein exhibited aberrant properties including mislocalization, failure to interact with mutant superoxide dismutase 1 (SOD1) and defective secretion. The CHGBL413 transgene in SOD1G37R mice precipitated disease onset and pathological changes related to misfolded SOD1 specifically in female mice. However, the CHGBL413 variant also slowed down disease progression in SOD1G37R mice, which is in line with a very slow disease progression that we report for a Swedish woman with ALS who is carrier of two mutant SOD1D90A alleles and two variant CHGBP413L and CHGBR458Q alleles. In contrast, overexpression of the common CHGBP413 allele in SOD1G37R mice did not affect disease onset but significantly accelerated disease progression and pathological changes. As in transgenic mice, the CHGBP413L allele conferred an earlier ALS disease onset in women of Japanese and French Canadian origins with less effect in men. Evidence is presented that the sex-dependent effects of CHGBL413 allelic variant in ALS may arise from enhanced neuronal expression of CHGB in females because of a sex-determining region Y element in the gene promoter. Thus, our results suggest that CHGB variants may act as modifiers of onset and progression in some ALS populations and especially in females because of higher expression levels compared to males.",
author = "Yasuyuki Ohta and Genevieve Soucy and Daniel Phaneuf and Audet, {Jean Nicolas} and Fran{\cc}ois Gros-Louis and Rouleau, {Guy A.} and H{\'e}l{\`e}ne Blasco and Philippe Corcia and Andersen, {Peter M.} and Frida Nordin and Toru Yamashita and Koji Abe and Julien, {Jean Pierre}",
year = "2016",
doi = "10.1093/hmg/ddw304",
language = "English",
volume = "25",
pages = "4771--4786",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "21",

}

TY - JOUR

T1 - Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis

AU - Ohta, Yasuyuki

AU - Soucy, Genevieve

AU - Phaneuf, Daniel

AU - Audet, Jean Nicolas

AU - Gros-Louis, François

AU - Rouleau, Guy A.

AU - Blasco, Hélène

AU - Corcia, Philippe

AU - Andersen, Peter M.

AU - Nordin, Frida

AU - Yamashita, Toru

AU - Abe, Koji

AU - Julien, Jean Pierre

PY - 2016

Y1 - 2016

N2 - Recent genetic studies yielded conflicting results regarding a role for the variant chromogranin B (CHGB)P413L allele as a disease modifier in ALS. Moreover, potential deleterious effects of the CHGBP413L variant in ALS pathology have not been investigated. Here we report that in transfected cultured cells, the variant CHGBL413 protein exhibited aberrant properties including mislocalization, failure to interact with mutant superoxide dismutase 1 (SOD1) and defective secretion. The CHGBL413 transgene in SOD1G37R mice precipitated disease onset and pathological changes related to misfolded SOD1 specifically in female mice. However, the CHGBL413 variant also slowed down disease progression in SOD1G37R mice, which is in line with a very slow disease progression that we report for a Swedish woman with ALS who is carrier of two mutant SOD1D90A alleles and two variant CHGBP413L and CHGBR458Q alleles. In contrast, overexpression of the common CHGBP413 allele in SOD1G37R mice did not affect disease onset but significantly accelerated disease progression and pathological changes. As in transgenic mice, the CHGBP413L allele conferred an earlier ALS disease onset in women of Japanese and French Canadian origins with less effect in men. Evidence is presented that the sex-dependent effects of CHGBL413 allelic variant in ALS may arise from enhanced neuronal expression of CHGB in females because of a sex-determining region Y element in the gene promoter. Thus, our results suggest that CHGB variants may act as modifiers of onset and progression in some ALS populations and especially in females because of higher expression levels compared to males.

AB - Recent genetic studies yielded conflicting results regarding a role for the variant chromogranin B (CHGB)P413L allele as a disease modifier in ALS. Moreover, potential deleterious effects of the CHGBP413L variant in ALS pathology have not been investigated. Here we report that in transfected cultured cells, the variant CHGBL413 protein exhibited aberrant properties including mislocalization, failure to interact with mutant superoxide dismutase 1 (SOD1) and defective secretion. The CHGBL413 transgene in SOD1G37R mice precipitated disease onset and pathological changes related to misfolded SOD1 specifically in female mice. However, the CHGBL413 variant also slowed down disease progression in SOD1G37R mice, which is in line with a very slow disease progression that we report for a Swedish woman with ALS who is carrier of two mutant SOD1D90A alleles and two variant CHGBP413L and CHGBR458Q alleles. In contrast, overexpression of the common CHGBP413 allele in SOD1G37R mice did not affect disease onset but significantly accelerated disease progression and pathological changes. As in transgenic mice, the CHGBP413L allele conferred an earlier ALS disease onset in women of Japanese and French Canadian origins with less effect in men. Evidence is presented that the sex-dependent effects of CHGBL413 allelic variant in ALS may arise from enhanced neuronal expression of CHGB in females because of a sex-determining region Y element in the gene promoter. Thus, our results suggest that CHGB variants may act as modifiers of onset and progression in some ALS populations and especially in females because of higher expression levels compared to males.

UR - http://www.scopus.com/inward/record.url?scp=85014869421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014869421&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddw304

DO - 10.1093/hmg/ddw304

M3 - Article

VL - 25

SP - 4771

EP - 4786

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 21

ER -